M. Pieroni

Myocarditis and COVID-19 related issues

I. Olivotto, L. Bolognese, M. Ciabatti, 2023, Global cardiology science & practice.

From atrial fibrillation management to atrial myopathy assessment: the evolving concept of left atrium disease in hypertrophic cardiomyopathy.

I. Olivotto, A. Milazzo, M. Ciabatti, 2024, The Canadian journal of cardiology.

Atlas of Regional Left Ventricular Scar in Nonischemic Cardiomyopathies

I. Olivotto, A. Guaricci, M. Ciabatti, 2024, JACC. Advances.

Effects of Enzyme Replacement Therapy on Cardiac MRI Findings in Fabry Disease: A Systematic Review and Meta-Analysis.

A. Camporeale, P. Masci, S. Figliozzi, 2024, Radiology. Cardiothoracic imaging.

Anderson-Fabry disease management: role of the cardiologist.

Robert J. Desnick, M. Pieroni, Mehdi Namdar, 2024, European heart journal.

Impact of GLA Variant Classification on the Estimated Prevalence of Fabry Disease: A Systematic Review and Meta-Analysis of Screening Studies

F. Graziani, M. Rubino, E. Monda, 2023, Circulation. Genomic and precision medicine.

Clinical staging of Anderson-Fabry cardiomyopathy: An operative proposal.

I. Olivotto, R. Lillo, F. Graziani, 2023, Heart failure reviews.

Real‐world candidacy to mavacamten in a contemporary hypertrophic obstructive cardiomyopathy population

C. Autore, G. Sinagra, F. Re, 2023, European journal of heart failure.